kw.\*:("Immunoradiothérapie")
Results 1 to 25 of 1280
Selection :
Radiothérapie métabolique = ImmunoradiotherapySIBILOT, D. Moro; VUILLEZ, J. P.Revue des maladies respiratoires. Supplément. 2001, Vol 18, Num 1, pp 1S133-1S134, issn 1166-8253Article
The radioisotope contributes significantly to the activity of radioimmunotherapyDAVIS, Thomas A; KAMINSKI, Mark S; LEVY, Ronald et al.Clinical cancer research. 2004, Vol 10, Num 23, pp 7792-7798, issn 1078-0432, 7 p.Article
Comparisons of sectioned micro-TLD dose measurements with predicted dose from 131I-labeled antibodyLANGMUIR, V. K; WESSELS, B. W; MENDONCA, H et al.Medical physics (Lancaster). 1992, Vol 19, Num 5, pp 1213-1218, issn 0094-2405Article
In vivo diagnosis and therapy of human tumors with monoclonal antibodies. II, Naples, Italy, 16-19 March 1988ECKELMAN, W. C; LARSON, S. M.Nuclear medicine and biology. 1989, Vol 16, Num 6, issn 0969-8051, I.VI, 613-668 [62 p.]Conference Proceedings
Pretargeted α emitting radioimmunotherapy using 213Bi 1,4,7,10-tetraazacyclododecane-N, N', N, N'''-tetraacetic acid-biotinZHENGSHENG YAO; MEILI ZHANG; PASTAN, Ira et al.Clinical cancer research. 2004, Vol 10, Num 9, pp 3137-3146, issn 1078-0432, 10 p.Article
Sacral scintigraphy for bone marrow dosimetry in radioimmunotherapySIEGEL, J. A; LEE, R. E; PAWLYK, D. A et al.Nuclear medicine and biology. 1989, Vol 16, Num 6, pp 553-559, issn 0969-8051, 6 p.Article
Intraperitoneal pretarget radioimmunotherapy with CC49 fusion proteinBUCHSBAUM, Donald J; KHAZAELI, M. B; AXWORTHY, Donald B et al.Clinical cancer research. 2005, Vol 11, Num 22, pp 8180-8185, issn 1078-0432, 6 p.Article
Radioimmunotherapy of malignancy using antibody targeted radionuclidesCOBB, L. M; HUMM, J. L.British journal of cancer. 1986, Vol 54, Num 6, pp 863-870, issn 0007-0920Article
Feasibility of radioimmunotherapy of experimental pneumococcal infectionDADACHOVA, E; BURNS, T; BRYAN, R. A et al.Antimicrobial agents and chemotherapy. 2004, Vol 48, Num 5, pp 1624-1629, issn 0066-4804, 6 p.Article
Radioimmunotherapy of cancer : arming the missilesGOLDENBERG, D. M; GRIFFITHS, G. L.JNM : (1990). 1992, Vol 33, Num 6, pp 1110-1112Article
Progress in radioimmunotherapyBAST, R. C.The New England journal of medicine. 1993, Vol 329, Num 17, pp 1266-1268, issn 0028-4793Article
Strategies for enhancement of radioimmunotherapyDENARDO, G; DENARDO, S; KUKIS, D et al.International journal of radiation applications and instrumentation. Part B. Nuclear medicine and biology. 1991, Vol 18, Num 6, pp 633-640, issn 0883-2897, 7 p.Conference Paper
New concepts in monoclonal antibody based radioimmunodiagnosis and radioimmunotherapy of carcinomaSCHLOM, J; MILENIC, D. E; ROSELLI, M et al.International journal of radiation applications and instrumentation. Part B. Nuclear medicine and biology. 1991, Vol 18, Num 4, pp 425-435, issn 0883-2897, 9 p.Conference Paper
Measurement of receptor concentration and forward-binding rate constant via radiopharmacokinetic modeling of technetium-99m-galactosyl-neoglycoalbuminVERA, D. R; STADALNIK, R. C; TRUDEAU, W. L et al.JNM. Journal of nuclear medicine (The) : (1990). 1991, Vol 32, Num 6, pp 1169-1176Article
Optimizing antibodies for use in nuclear medicineKASSIS, A. I.JNM. Journal of nuclear medicine (The) : (1990). 1991, Vol 32, Num 9, pp 1751-1753Article
Nonantigen-specific tissue localization of monoclonal antibodiesMASSUGER, L; CLAESSENS, R; KENEMANS, P et al.The Journal of nuclear medicine (1978). 1990, Vol 31, Num 8, issn 0161-5505, p. 1438Article
Radioactive gold cluster immunocongugates: potential agents for cancer therapyHAINFELD, J. F; FOLEY, C. J; SRIVASTAVA, S. C et al.International journal of radiation applications and instrumentation. Part B. Nuclear medicine and biology. 1990, Vol 17, Num 3, pp 287-294, issn 0883-2897, 7 p.Article
Radioimmunotherapy of cancer: clinical studies and limiting factorsDYKES, P. W; BRADWELL, A. R; CHAPMAN, C. E et al.Cancer treatment reviews. 1987, Vol 14, Num 2, pp 87-106, issn 0305-7372Article
Macroscopic dosimetry for radioimmunotherapy: nonuniform activity distributions in solid tumorsHOWELL, R. W; RAO, D. V; SASTRY, K. S. R et al.Medical physics (Lancaster). 1989, Vol 16, Num 1, pp 66-74, issn 0094-2405, 9 p.Article
Targeting of cancer with radiolabeled antibodies: prospects for imaging and therapyGOLDENBERG, D. M.Archives of pathology & laboratory medicine (1976). 1988, Vol 112, Num 6, pp 580-587, issn 0363-0153Article
Combining radioimmunotherapy with antihypoxia therapy 2-deoxy-D-glucose results in reduction of therapeutic efficacyDEARLING, Jason L. J; QURESHI, Uzma; BEGENT, Richard H. J et al.Clinical cancer research. 2007, Vol 13, Num 6, pp 1903-1910, issn 1078-0432, 8 p.Article
A technical analysis of an intraoperative radiation detection probeWILSON, L. A; KUHN, J. A; CORBISIERO, R. M et al.Medical physics (Lancaster). 1992, Vol 19, Num 5, pp 1219-1223, issn 0094-2405Article
Pharmacokinetics, immune response, and biodistribution of iodine-131-labeled chimeric mouse/human IgG1,k 17-1A monoclonal antibodyMEREDITH, R. F; LOBUGLIO, A. F; WHEELER, R. H et al.JNM. Journal of nuclear medicine (The) : (1990). 1991, Vol 32, Num 6, pp 1162-1168Article
The future of radioimmunotherapy : A PET perspectiveCONTI, Peter S.Seminars in oncology. 2005, Vol 32, Num 1, pp S63-S67, issn 0093-7754, SUP1Conference Paper
Tasrgeting and therapy of human glioma xenografts in vivo using radiolabeled antibodiesWILLIAMS, J. A; EDWARDS, J. A; WESSELS, B. W et al.International journal of radiation oncology, biology, physics. 1990, Vol 19, Num 3, pp 633-642, issn 0360-3016Article